Tripodo, Claudio

Publishing since 2003 (Junior)

Has published 22 publications in 8 years

Number of publications published per year by Tripodo, Claudio. (Source : PubMed)

Distribution of publications types for Tripodo, Claudio. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Frossi B, Gri G, Tripodo C, Pucillo C. Exploring a regulatory role for mast cells: 'MCregs'?  Trends Immunol.  2010;31;3  
•  Merluzzi S, Frossi B, Gri G, Parusso S, Tripodo C, Pucillo C. Mast cells enhance proliferation of B lymphocytes and drive their differentiation towards IgA-secreting plasma cells.  Blood  2010  
•  Petta S, Cammà C, Scazzone C, Tripodo C, Di Marco V, Bono A, Cabibi D, Licata G, Porcasi R, Marchesini G, Craxí A. Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C.  Hepatology  2009  
•  Tripodo C, Iannitto E, Florena AM, Pucillo CE, Piccaluga PP, Franco V, Pileri SA. Gamma-delta T-cell lymphomas.  Nat Rev Clin Oncol  2009;6;12  
•  Piconese S, Gri G, Tripodo C, Musio S, Gorzanelli A, Frossi B, Pedotti R, Pucillo CE, Colombo MP. Mast cells counteract regulatory T-cell suppression through interleukin-6 and OX40/OX40L axis toward Th17-cell differentiation.  Blood  2009;114;13  
•  Tripodo C, Florena AM, Macor P, Di Bernardo A, Porcasi R, Guarnotta C, Ingrao S, Zerilli M, Secco E, Todaro M, Tedesco F, Franco V. P-selectin glycoprotein ligand-1 as a potential target for humoral immunotherapy of multiple myeloma.  Curr Cancer Drug Targets  2009;9;5  
•  Tarantino G, Marco VD, Petta S, Almasio PL, Barbaria F, Licata A, Bosco GL, Tripodo C, Stefano RD, Craxì A. Serum BLyS/BAFF predicts the outcome of acute hepatitis C virus infection.  J. Viral Hepat.  2009;16;6  
•  Zucchetto A, Benedetti D, Tripodo C, Bomben R, Dal Bo M, Marconi D, Bossi F, Lorenzon D, Degan M, Rossi FM, Rossi D, Bulian P, Franco V, Del Poeta G, Deaglio S, Gaidano G, Tedesco F, Malavasi F, Gattei V. CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival.  Cancer Res.  2009;69;9  
•  Bossi F, Rizzi L, Bulla R, Debeus A, Tripodo C, Picotti P, Betto E, Macor P, Pucillo C, Würzner R, Tedesco F. C7 is expressed on endothelial cells as a trap for the assembling terminal complement complex and may exert anti-inflammatory function.  Blood  2009;113;15  
•  Florena AM, Tripodo C, Di Bernardo A, Iannitto E, Guarnotta C, Porcasi R, Ingrao S, Abbadessa V, Franco V. Different immunophenotypical apoptotic profiles characterise megakaryocytes of essential thrombocythaemia and primary myelofibrosis.  J. Clin. Pathol.  2009;62;4  

[ See timeline ] [ See all publications ]